Ensuring the Safety and Efficacy of Biopharmaceuticals with resDetect™ Residual Detection Solutions

resDetect™ is a series of reagent kits designed to follow international legal and regulatory requirements and guidelines for the detection of residual components in the biopharmaceutical manufacturing process. These kits cover various applications related to process-related residue detection for biopharmaceuticals, including antibody drugs, cell and gene therapies (CGT), vaccines, and more;During the production of various bioproducts such as cell/gene therapy drugs, therapeutic antibodies, vaccines, etc., the residual nucleic acids can impact the quality and safety of the final product. To ensure the safety and efficacy of related products, regulatory agencies in various countries have imposed strict limits on the amount of nucleic acid residues in bioproducts.

During the production of various bioproducts such as cell/gene therapy drugs, therapeutic antibodies, vaccines, etc., the residual nucleic acids can impact the quality and safety of the final product. To ensure the safety and efficacy of related products, regulatory agencies in various countries have imposed strict limits on the amount of nucleic acid residues in bioproducts.